186 related articles for article (PubMed ID: 23538388)
21. Impact of a CXCL12/CXCR4 Antagonist in Bleomycin (BLM) Induced Pulmonary Fibrosis and Carbon Tetrachloride (CCl4) Induced Hepatic Fibrosis in Mice.
Chow LN; Schreiner P; Ng BY; Lo B; Hughes MR; Scott RW; Gusti V; Lecour S; Simonson E; Manisali I; Barta I; McNagny KM; Crawford J; Webb M; Underhill TM
PLoS One; 2016; 11(3):e0151765. PubMed ID: 26998906
[TBL] [Abstract][Full Text] [Related]
22. Noninvasive imaging reveals inhibition of ovarian cancer by targeting CXCL12-CXCR4.
Ray P; Lewin SA; Mihalko LA; Schmidt BT; Luker KE; Luker GD
Neoplasia; 2011 Dec; 13(12):1152-61. PubMed ID: 22241961
[TBL] [Abstract][Full Text] [Related]
23. Proof of activity with AMD11070, an orally bioavailable inhibitor of CXCR4-tropic HIV type 1.
Moyle G; DeJesus E; Boffito M; Wong RS; Gibney C; Badel K; MacFarland R; Calandra G; Bridger G; Becker S;
Clin Infect Dis; 2009 Mar; 48(6):798-805. PubMed ID: 19193109
[TBL] [Abstract][Full Text] [Related]
24. Experimental study of the inhibition effect of CXCL12/CXCR4 in malignant pleural mesothelioma.
Li J; Li T; Li S; Xie L; Yang YL; Lin Q; Kadoch O; Li H; Hou S; Xu Z
J Investig Med; 2019 Feb; 67(2):338-345. PubMed ID: 30367010
[TBL] [Abstract][Full Text] [Related]
25. Peroxisome proliferator‑activated receptor γ agonist rosiglitazone inhibits migration and invasion of prostate cancer cells through inhibition of the CXCR4/CXCL12 axis.
Qin L; Gong C; Chen AM; Guo FJ; Xu F; Ren Y; Liao H
Mol Med Rep; 2014 Aug; 10(2):695-700. PubMed ID: 24842333
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of the CXCL12/CXCR4-axis as preventive therapy for radiation-induced pulmonary fibrosis.
Shu HK; Yoon Y; Hong S; Xu K; Gao H; Hao C; Torres-Gonzalez E; Nayra C; Rojas M; Shim H
PLoS One; 2013; 8(11):e79768. PubMed ID: 24244561
[TBL] [Abstract][Full Text] [Related]
27. Curcumin modulates SDF-1alpha/CXCR4-induced migration of human retinal endothelial cells (HRECs).
Sameermahmood Z; Balasubramanyam M; Saravanan T; Rema M
Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3305-11. PubMed ID: 18660423
[TBL] [Abstract][Full Text] [Related]
28. Murine B16 melanomas expressing high levels of the chemokine stromal-derived factor-1/CXCL12 induce tumor-specific T cell chemorepulsion and escape from immune control.
Vianello F; Papeta N; Chen T; Kraft P; White N; Hart WK; Kircher MF; Swart E; Rhee S; Palù G; Irimia D; Toner M; Weissleder R; Poznansky MC
J Immunol; 2006 Mar; 176(5):2902-14. PubMed ID: 16493048
[TBL] [Abstract][Full Text] [Related]
29. Human melanoma metastases express functional CXCR4.
Scala S; Giuliano P; Ascierto PA; Ieranò C; Franco R; Napolitano M; Ottaiano A; Lombardi ML; Luongo M; Simeone E; Castiglia D; Mauro F; De Michele I; Calemma R; Botti G; Caracò C; Nicoletti G; Satriano RA; Castello G
Clin Cancer Res; 2006 Apr; 12(8):2427-33. PubMed ID: 16638848
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases.
Kim SY; Lee CH; Midura BV; Yeung C; Mendoza A; Hong SH; Ren L; Wong D; Korz W; Merzouk A; Salari H; Zhang H; Hwang ST; Khanna C; Helman LJ
Clin Exp Metastasis; 2008; 25(3):201-11. PubMed ID: 18071913
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of CXCR4 activity with AMD3100 decreases invasion of human colorectal cancer cells in vitro.
Li JK; Yu L; Shen Y; Zhou LS; Wang YC; Zhang JH
World J Gastroenterol; 2008 Apr; 14(15):2308-13. PubMed ID: 18416455
[TBL] [Abstract][Full Text] [Related]
32. Fluorescent CXCL12AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies.
Hatse S; Princen K; Liekens S; Vermeire K; De Clercq E; Schols D
Cytometry A; 2004 Oct; 61(2):178-88. PubMed ID: 15382150
[TBL] [Abstract][Full Text] [Related]
33. "CXCR4-CXCL12 and VEGF correlate to uveal melanoma progression".
Franco R; Botti G; Mascolo M; Loquercio G; Liguori G; Ilardi G; Losito S; La Mura A; Calemma R; Ierano C; Bryce J; D'Alterio C; Scala S
Front Biosci (Elite Ed); 2010 Jan; 2(1):13-21. PubMed ID: 20036848
[TBL] [Abstract][Full Text] [Related]
34. A locked, dimeric CXCL12 variant effectively inhibits pulmonary metastasis of CXCR4-expressing melanoma cells due to enhanced serum stability.
Takekoshi T; Ziarek JJ; Volkman BF; Hwang ST
Mol Cancer Ther; 2012 Nov; 11(11):2516-25. PubMed ID: 22869557
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the molecular pharmacology of AMD3100: a specific antagonist of the G-protein coupled chemokine receptor, CXCR4.
Fricker SP; Anastassov V; Cox J; Darkes MC; Grujic O; Idzan SR; Labrecque J; Lau G; Mosi RM; Nelson KL; Qin L; Santucci Z; Wong RS
Biochem Pharmacol; 2006 Aug; 72(5):588-96. PubMed ID: 16815309
[TBL] [Abstract][Full Text] [Related]
36. Antifibrotic effects of CXCR4 antagonist in bleomycin-induced pulmonary fibrosis in mice.
Makino H; Aono Y; Azuma M; Kishi M; Yokota Y; Kinoshita K; Takezaki A; Kishi J; Kawano H; Ogawa H; Uehara H; Izumi K; Sone S; Nishioka Y
J Med Invest; 2013; 60(1-2):127-37. PubMed ID: 23614921
[TBL] [Abstract][Full Text] [Related]
37. The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis.
Arya M; Patel HR; McGurk C; Tatoud R; Klocker H; Masters J; Williamson M
J Exp Ther Oncol; 2004 Dec; 4(4):291-303. PubMed ID: 15844659
[TBL] [Abstract][Full Text] [Related]
38. Hypoxia increases the metastatic ability of breast cancer cells via upregulation of CXCR4.
Cronin PA; Wang JH; Redmond HP
BMC Cancer; 2010 May; 10():225. PubMed ID: 20492653
[TBL] [Abstract][Full Text] [Related]
39. Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4.
Hatse S; Princen K; Bridger G; De Clercq E; Schols D
FEBS Lett; 2002 Sep; 527(1-3):255-62. PubMed ID: 12220670
[TBL] [Abstract][Full Text] [Related]
40. The CXCR4/CXCL12 axis in cutaneous malignancies with an emphasis on melanoma.
Mitchell B; Mahalingam M
Histol Histopathol; 2014 Dec; 29(12):1539-46. PubMed ID: 24879309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]